Wide Ranks

ABP

Abpro Holdings, Inc

2.68

Top Statistics
Market Cap 138 M Forward PE 0.0000 Revenue Growth 0.00 %
Current Ratio 0.15 Trailing PE 0.0000 Earnings Growth 0.00 %
Profit Margins 0.00 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA -9.49 Enterprise / Revenue 1489.85 Price To Sales Trailing12 Months 1917.64
Profitability
Profit Margins 0.00 % Operating Margins -15975.00 %
Balance Sheet
Total Cash 63000 Total Cash Per Share 0.0070 Total Debt 6 M
Total Debt To Equity Current Ratio 0.15 Book Value Per Share -9.30
All Measures
Short Ratio 13.00 % Message Board Id finmb_323344854 City Woburn
Uuid fb8e886d-6efe-3bfd-bb19-867bf881b765 Previous Close 2.90 First Trade Date Epoch Utc 1 B
Book Value -9.30 Total Debt 6 M Volume 40576
Fifty Two Week Low 2.50 Total Cash Per Share 0.0070 Total Revenue 72000
Max Age 86400 Sand P52 Week Change 0.3133 Operating Margins -15975.00 %
Net Income To Common -8087000 Implied Shares Outstanding 49 M Trailing Peg Ratio None
Last Fiscal Year End 1 B Average Daily Volume10 Day 43800 Average Volume10days 43800
Total Cash 63000 Next Fiscal Year End 1 B Revenue Per Share 0.0080
Held Percent Insiders 0.4759 Trailing PE 0.0000 Date Short Interest 1 B
Most Recent Quarter 1 B Regular Market Previous Close 2.90 Target Low Price 0.0000
Gmt Off Set Milliseconds -18000000 Fifty Day Average 9.37 Open 2.88
Dividend Yield 0.00 % State MA Time Zone Short Name EST
Trailing Eps -0.3200 Day Low 2.50 Address1 68 Cummings Park Drive
Shares Outstanding 51 M Price Hint 4 Target High Price 0.0000
Website https://abpro.com 52 Week Change -0.7472 Average Volume 18551
Recommendation Key none Forward Eps 0.0000 Compensation As Of Epoch Date 1 B
Quick Ratio 1.40 % Is_sp_500 False Regular Market Day High 2.88
Profit Margins 0.00 % Fifty Two Week High 13.00 Day High 2.88
Shares Short 13783 Regular Market Open 2.88 Industry Key biotechnology
Earnings Growth 0.00 % Enterprise To Revenue 1489.85 Revenue Growth 0.00 %
Shares Percent Shares Out 0.0003 Operating Cashflow -8313000 Currency USD
Time Zone Full Name America/New_York Market Cap 138 M Is_nasdaq_100 False
Zip 01801 Quote Type EQUITY Industry Biotechnology
Long Name Abpro Holdings, Inc. Regular Market Day Low 2.50 Held Percent Institutions 0.0075
Current Price 2.68 Enterprise To Ebitda -9.49 Financial Currency USD
Current Ratio 0.15 Industry Disp Biotechnology Country United States
Two Hundred Day Average 10.63 Enterprise Value 107 M Price To Sales Trailing12 Months 1917.64
Forward PE 0.0000 Regular Market Volume 40576 Ebitda -11307000
Exchange NGM
Go to Yahoo Finance Go to Seeking Alpha 
Abpro Holdings, Inc., a biotechnology company, engages in developing antibody therapeutics for patients with immuno-oncology, ophthalmology, and autoimmunity issues.

Its platform DiversImmune addresses a bottleneck in the antibody therapeutics industry.

Its lead product candidates include ABP-100 for the treatment of breast, gastric, and colorectal cancers; and ABP-201 for the treatment of vascular diseases of the eye.

The company has a strategic partnership with Abpro Bio Co.

Ltd and NJCTTQ.

The company was formerly known as Abpro Corporation and changed its name to Abpro Holdings, Inc. in November 2024.

Abpro Holdings, Inc. was incorporated in 2004 and is headquartered in Woburn, Massachusetts.